1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neohespiridine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neohespiridine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neohespiridine by Country/Region, 2018, 2022 & 2029
2.2 Neohespiridine Segment by Type
2.2.1 Industrial Grade
2.2.2 Food Grade
2.2.3 Pharmacy Grade
2.3 Neohespiridine Sales by Type
2.3.1 Global Neohespiridine Sales Market Share by Type (2018-2023)
2.3.2 Global Neohespiridine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neohespiridine Sale Price by Type (2018-2023)
2.4 Neohespiridine Segment by Application
2.4.1 Food
2.4.2 Medicine
2.4.3 Chemical
2.4.4 Cosmetics
2.4.5 Other
2.5 Neohespiridine Sales by Application
2.5.1 Global Neohespiridine Sale Market Share by Application (2018-2023)
2.5.2 Global Neohespiridine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neohespiridine Sale Price by Application (2018-2023)
3 Global Neohespiridine by Company
3.1 Global Neohespiridine Breakdown Data by Company
3.1.1 Global Neohespiridine Annual Sales by Company (2018-2023)
3.1.2 Global Neohespiridine Sales Market Share by Company (2018-2023)
3.2 Global Neohespiridine Annual Revenue by Company (2018-2023)
3.2.1 Global Neohespiridine Revenue by Company (2018-2023)
3.2.2 Global Neohespiridine Revenue Market Share by Company (2018-2023)
3.3 Global Neohespiridine Sale Price by Company
3.4 Key Manufacturers Neohespiridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neohespiridine Product Location Distribution
3.4.2 Players Neohespiridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neohespiridine by Geographic Region
4.1 World Historic Neohespiridine Market Size by Geographic Region (2018-2023)
4.1.1 Global Neohespiridine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neohespiridine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neohespiridine Market Size by Country/Region (2018-2023)
4.2.1 Global Neohespiridine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neohespiridine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neohespiridine Sales Growth
4.4 APAC Neohespiridine Sales Growth
4.5 Europe Neohespiridine Sales Growth
4.6 Middle East & Africa Neohespiridine Sales Growth
5 Americas
5.1 Americas Neohespiridine Sales by Country
5.1.1 Americas Neohespiridine Sales by Country (2018-2023)
5.1.2 Americas Neohespiridine Revenue by Country (2018-2023)
5.2 Americas Neohespiridine Sales by Type
5.3 Americas Neohespiridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neohespiridine Sales by Region
6.1.1 APAC Neohespiridine Sales by Region (2018-2023)
6.1.2 APAC Neohespiridine Revenue by Region (2018-2023)
6.2 APAC Neohespiridine Sales by Type
6.3 APAC Neohespiridine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neohespiridine by Country
7.1.1 Europe Neohespiridine Sales by Country (2018-2023)
7.1.2 Europe Neohespiridine Revenue by Country (2018-2023)
7.2 Europe Neohespiridine Sales by Type
7.3 Europe Neohespiridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neohespiridine by Country
8.1.1 Middle East & Africa Neohespiridine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neohespiridine Revenue by Country (2018-2023)
8.2 Middle East & Africa Neohespiridine Sales by Type
8.3 Middle East & Africa Neohespiridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neohespiridine
10.3 Manufacturing Process Analysis of Neohespiridine
10.4 Industry Chain Structure of Neohespiridine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neohespiridine Distributors
11.3 Neohespiridine Customer
12 World Forecast Review for Neohespiridine by Geographic Region
12.1 Global Neohespiridine Market Size Forecast by Region
12.1.1 Global Neohespiridine Forecast by Region (2024-2029)
12.1.2 Global Neohespiridine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neohespiridine Forecast by Type
12.7 Global Neohespiridine Forecast by Application
13 Key Players Analysis
13.1 DuPont
13.1.1 DuPont Company Information
13.1.2 DuPont Neohespiridine Product Portfolios and Specifications
13.1.3 DuPont Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DuPont Main Business Overview
13.1.5 DuPont Latest Developments
13.2 Changsha Sunnycare
13.2.1 Changsha Sunnycare Company Information
13.2.2 Changsha Sunnycare Neohespiridine Product Portfolios and Specifications
13.2.3 Changsha Sunnycare Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Changsha Sunnycare Main Business Overview
13.2.5 Changsha Sunnycare Latest Developments
13.3 Biospringer
13.3.1 Biospringer Company Information
13.3.2 Biospringer Neohespiridine Product Portfolios and Specifications
13.3.3 Biospringer Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biospringer Main Business Overview
13.3.5 Biospringer Latest Developments
13.4 Gelfix
13.4.1 Gelfix Company Information
13.4.2 Gelfix Neohespiridine Product Portfolios and Specifications
13.4.3 Gelfix Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gelfix Main Business Overview
13.4.5 Gelfix Latest Developments
13.5 CP Kelco
13.5.1 CP Kelco Company Information
13.5.2 CP Kelco Neohespiridine Product Portfolios and Specifications
13.5.3 CP Kelco Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CP Kelco Main Business Overview
13.5.5 CP Kelco Latest Developments
13.6 Kang Biotech
13.6.1 Kang Biotech Company Information
13.6.2 Kang Biotech Neohespiridine Product Portfolios and Specifications
13.6.3 Kang Biotech Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kang Biotech Main Business Overview
13.6.5 Kang Biotech Latest Developments
13.7 BASF SE
13.7.1 BASF SE Company Information
13.7.2 BASF SE Neohespiridine Product Portfolios and Specifications
13.7.3 BASF SE Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BASF SE Main Business Overview
13.7.5 BASF SE Latest Developments
13.8 Bordas Distillations Chinchurreta
13.8.1 Bordas Distillations Chinchurreta Company Information
13.8.2 Bordas Distillations Chinchurreta Neohespiridine Product Portfolios and Specifications
13.8.3 Bordas Distillations Chinchurreta Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bordas Distillations Chinchurreta Main Business Overview
13.8.5 Bordas Distillations Chinchurreta Latest Developments
13.9 Golden Health
13.9.1 Golden Health Company Information
13.9.2 Golden Health Neohespiridine Product Portfolios and Specifications
13.9.3 Golden Health Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Golden Health Main Business Overview
13.9.5 Golden Health Latest Developments
13.10 Cargill
13.10.1 Cargill Company Information
13.10.2 Cargill Neohespiridine Product Portfolios and Specifications
13.10.3 Cargill Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cargill Main Business Overview
13.10.5 Cargill Latest Developments
13.11 Okay Pharmaceutical
13.11.1 Okay Pharmaceutical Company Information
13.11.2 Okay Pharmaceutical Neohespiridine Product Portfolios and Specifications
13.11.3 Okay Pharmaceutical Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Okay Pharmaceutical Main Business Overview
13.11.5 Okay Pharmaceutical Latest Developments
13.12 FMC Health and Nutrition
13.12.1 FMC Health and Nutrition Company Information
13.12.2 FMC Health and Nutrition Neohespiridine Product Portfolios and Specifications
13.12.3 FMC Health and Nutrition Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 FMC Health and Nutrition Main Business Overview
13.12.5 FMC Health and Nutrition Latest Developments
13.13 Nutrafur
13.13.1 Nutrafur Company Information
13.13.2 Nutrafur Neohespiridine Product Portfolios and Specifications
13.13.3 Nutrafur Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Nutrafur Main Business Overview
13.13.5 Nutrafur Latest Developments
13.14 Chr.Hansen Holding A/S
13.14.1 Chr.Hansen Holding A/S Company Information
13.14.2 Chr.Hansen Holding A/S Neohespiridine Product Portfolios and Specifications
13.14.3 Chr.Hansen Holding A/S Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Chr.Hansen Holding A/S Main Business Overview
13.14.5 Chr.Hansen Holding A/S Latest Developments
13.15 Layn
13.15.1 Layn Company Information
13.15.2 Layn Neohespiridine Product Portfolios and Specifications
13.15.3 Layn Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Layn Main Business Overview
13.15.5 Layn Latest Developments
13.16 Corbion NV
13.16.1 Corbion NV Company Information
13.16.2 Corbion NV Neohespiridine Product Portfolios and Specifications
13.16.3 Corbion NV Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Corbion NV Main Business Overview
13.16.5 Corbion NV Latest Developments
13.17 Hanfang
13.17.1 Hanfang Company Information
13.17.2 Hanfang Neohespiridine Product Portfolios and Specifications
13.17.3 Hanfang Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Hanfang Main Business Overview
13.17.5 Hanfang Latest Developments
13.18 Lianyuan Kangbiotech
13.18.1 Lianyuan Kangbiotech Company Information
13.18.2 Lianyuan Kangbiotech Neohespiridine Product Portfolios and Specifications
13.18.3 Lianyuan Kangbiotech Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lianyuan Kangbiotech Main Business Overview
13.18.5 Lianyuan Kangbiotech Latest Developments
13.19 Firmenich SA
13.19.1 Firmenich SA Company Information
13.19.2 Firmenich SA Neohespiridine Product Portfolios and Specifications
13.19.3 Firmenich SA Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Firmenich SA Main Business Overview
13.19.5 Firmenich SA Latest Developments
14 Research Findings and Conclusion
| ※参考情報 ネオヘスピリジン（Neohespiridine）は、主に柑橘類に含まれるフラボノイドの一種であり、特にオレンジやグレープフルーツの皮に多く存在している化合物です。この物質は、最近の研究により注目を集めており、食品や医療分野においてその利用可能性が探求されています。以下に、ネオヘスピリジンの概念や特徴、用途などについて詳しく述べていきます。 ネオヘスピリジンは、リモニンやヘスぺリジンといった他のフラボノイドと同様に、ポリフェノールの一種であり、抗酸化作用を持つとされています。その構造は、主にフラボン骨格に糖オリゴマーを持つことから、特異な生理活性を示すことが確認されています。また、ネオヘスピリジンの揮発性は低いため、食品において安定的な特性を持っていることが、商業的利用における魅力の一つとされています。 ネオヘスピリジンの特徴として、まず第一に挙げられるのはその甘味による風味改善効果です。一般的に糖分と比較しても低カロリーであり、砂糖の数倍の甘味を持つことから、カロリー制限を重視する製品において、代替甘味料としての可能性があります。また、この物質は苦味をマスキングする能力があるため、苦味を持つ食品や飲料の味を和らげるための添加物としての利用も期待されています。 多くの食品加工業者は、健康志向の高まりを受けて、ネオヘスピリジンを利用した製品開発に取り組んでいます。特に飲料業界においては、炭酸飲料やジュース、アルコール飲料などにおいて、その風味改善効果を活かす試みが行われています。ネオヘスピリジンにより、工業的に添加物が必要とされる甘味を補完することが可能であり、消費者からの受け入れも期待できるでしょう。 医療分野においても、ネオヘスピリジンに関連する研究が進められています。近年の研究によると、ネオヘスピリジンは抗酸化作用や抗炎症作用を持つことが示唆されており、これが健康維持や疾病予防に役立つ可能性があるとされています。特に、細胞の酸化ストレスを軽減することで、老化や様々な病気の予防に寄与することが期待されています。また、ネオヘスピリジンが持つ抗癌作用についての研究も進行中であり、今後の報告が待たれます。 さらに、ネオヘスピリジンの利用は、農業においても注目されています。特に、農薬や肥料の代替品としての可能性が研究されており、環境に優しい栽培方法の確立に寄与することが期待されています。このような取り組みは、持続可能な農業の実現に向けて重要なステップとなるでしょう。 ネオヘスピリジンに関連する技術的進歩も目覚ましい状況です。例えば、合成技術の向上により、天然由来のネオヘスピリジンを効果的に生産する方法が発展しています。これにより、大規模な商業生産が可能となり、コストの削減にも繋がるでしょう。また、分析技術の向上により、この物質の含有量や効果を簡便かつ迅速に測定できるようになり、品質管理が行いやすくなっています。 最後に、ネオヘスピリジンの未来について考えると、様々な分野においてその利用が拡大していく可能性が高いと考えられます。特に、健康志向の高い消費者に向けた製品開発や、持続可能性を意識した農業への適用が注目されるでしょう。ネオヘスピリジンの持つ特性を最大限に活かし、新たな価値を創出することが求められています。今後の研究や技術革新が、さらに多様な可能性を切り拓いていくことを期待しています。 このように、ネオヘスピリジンは食品や医療、農業の領域での利用が期待される多機能性の化合物であり、その研究と応用はまだ始まったばかりです。今後の展開が楽しみな分野であると言えるでしょう。 |
